CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PERMIDES aims to enhance the competitiveness of Personalized Medicine in Europe, focusing on oncology. The project fosters collaboration between biopharmaceutical and IT sectors to address innovation barriers through workshops and matchmaking events, ultimately supporting SMEs in developing innovative solutions.
It is the aim of PERMIDES to strenghten the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment).
Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods based.Via a cross-clusterin…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, Halden
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, DARMSTADT
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
